1. Home
  2. MGLD vs MYO Comparison

MGLD vs MYO Comparison

Compare MGLD & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGLD
  • MYO
  • Stock Information
  • Founded
  • MGLD 1996
  • MYO 2004
  • Country
  • MGLD United States
  • MYO United States
  • Employees
  • MGLD N/A
  • MYO N/A
  • Industry
  • MGLD Finance/Investors Services
  • MYO Industrial Specialties
  • Sector
  • MGLD Finance
  • MYO Health Care
  • Exchange
  • MGLD Nasdaq
  • MYO Nasdaq
  • Market Cap
  • MGLD 44.8M
  • MYO 36.5M
  • IPO Year
  • MGLD N/A
  • MYO 2017
  • Fundamental
  • Price
  • MGLD $1.03
  • MYO $0.83
  • Analyst Decision
  • MGLD
  • MYO Strong Buy
  • Analyst Count
  • MGLD 0
  • MYO 3
  • Target Price
  • MGLD N/A
  • MYO $7.83
  • AVG Volume (30 Days)
  • MGLD 9.5K
  • MYO 1.2M
  • Earning Date
  • MGLD 11-07-2025
  • MYO 11-10-2025
  • Dividend Yield
  • MGLD N/A
  • MYO N/A
  • EPS Growth
  • MGLD N/A
  • MYO N/A
  • EPS
  • MGLD N/A
  • MYO N/A
  • Revenue
  • MGLD $29,207,000.00
  • MYO $40,760,091.00
  • Revenue This Year
  • MGLD N/A
  • MYO $24.69
  • Revenue Next Year
  • MGLD N/A
  • MYO $20.91
  • P/E Ratio
  • MGLD N/A
  • MYO N/A
  • Revenue Growth
  • MGLD N/A
  • MYO 93.08
  • 52 Week Low
  • MGLD $0.64
  • MYO $0.79
  • 52 Week High
  • MGLD $2.10
  • MYO $7.17
  • Technical
  • Relative Strength Index (RSI)
  • MGLD 50.10
  • MYO 36.62
  • Support Level
  • MGLD $0.99
  • MYO $0.81
  • Resistance Level
  • MGLD $1.06
  • MYO $0.88
  • Average True Range (ATR)
  • MGLD 0.03
  • MYO 0.07
  • MACD
  • MGLD -0.01
  • MYO -0.02
  • Stochastic Oscillator
  • MGLD 39.13
  • MYO 13.10

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: